What deals has Ampersand Capital Partners done recently?

PE Firm · Capital Allocator

Ampersand Capital Partners

Medium

Not on record · Website

Last verified

11/4/2026

Firm Overview

At least 68

Portfolio tracked

Sectors

Regions

11/4/2026

Last verified

Ampersand Capital Partners is a private equity firm. Public-source enrichment is in progress.

Deals on record

1 on record in the index

Add-on

Flagship Biosciences, an Ampersand Capital Partners portfolio company, acquired Lanterne Dx

2026-10-14

Source: linkedin.com

Deals are listed only where a public source names both sides. Submit a correction.

Portfolio on record

Portfolio by sector

Unclassified38 of 68
Industrials12 of 68
Business Services11 of 68
Healthcare7 of 68

68 portfolio companies on record in the index, grouped by sector hub.

Current and exited

Current: 34 of 68Exited: 34 of 68

Portfolio size among all firms

At least 68 companies on record, more than 75% of the 405 firms in the index.

0885 companies (log scale)

Partial portfolio on record.

Portfolio Companies

Company	Sector	Status	Website
Adaptas Solutions	Laboratory Products	Exited	Visit ↗
Admera Health	Laboratory Services	Current	Visit ↗
Agilux Laboratories	Laboratory Services	Exited	Visit ↗
AKEURA (fka P95 Julius Clinical)	Pharma Services	Current	Visit ↗
Alcami	Contract Manufacturing	Current	Visit ↗
AnaBios	Laboratory Services	Current	Visit ↗
ANI Pharmaceuticals	Specialty Products	Current	Visit ↗
Arranta Bio	Contract Manufacturing	Exited	Visit ↗
Avid Bioservices	Contract Manufacturing	Current	Visit ↗
Avista Pharma Solutions	Contract Manufacturing	Exited	Visit ↗
Bako Diagnostics	Laboratory Services	Exited	Visit ↗
Beacon Intelligence	Pharma Services	Current	Visit ↗
BioClinica	Pharma Services	Exited	Visit ↗
Biologos	Laboratory Products	Current	Visit ↗
Biosynth	Laboratory Products	Current	Visit ↗
Bioventus	Specialty Products	Exited	Visit ↗
Brammer Bio	Contract Manufacturing	Exited	Visit ↗
Canopy Biosciences	Laboratory Products	Exited	Visit ↗
Cellero	Laboratory Services	Exited	Visit ↗
ChanTest	Laboratory Services	Exited	Visit ↗
Confluent Medical Technologies	Contract Manufacturing	Current	Visit ↗
Corpus Medical	Contract Manufacturing	Exited	Visit ↗
CRI Lifetree	Pharma Services	Exited	Visit ↗
CurTec	Specialty Products	Current	Visit ↗
CutisPharma	Specialty Products	Exited	Visit ↗
Dynex Technologies	Laboratory Products	Exited	Visit ↗
Elite One Source	Contract Manufacturing	Exited	Visit ↗
ETE Medical	Contract Manufacturing	Exited	Visit ↗
Gannet BioChem	Contract Manufacturing	Current	Visit ↗
GenDx	Laboratory Products	Exited	Visit ↗
GENEWIZ	Laboratory Services	Exited	Visit ↗
Genezen	Contract Manufacturing	Current	Visit ↗
Genoptix	Laboratory Services	Exited	Visit ↗
Gyros Protein Technologies	Laboratory Products	Exited	Visit ↗
Innovative Food Processors	Contract Manufacturing	Exited	Visit ↗
Interpace Biosciences	Laboratory Services	Current	Visit ↗
iuvo	Pharma Services	Current	Visit ↗
Kedrion Biopharma	Specialty Products	Current	Visit ↗
LakePharma	Contract Manufacturing	Exited	Visit ↗
Lanterne Dx (fka Flagship Biosciences)	Laboratory Services	Current	Visit ↗
Leinco Technologies, Inc.	Laboratory Products	Current	Visit ↗
Lexington Medical	Not on record	Current	Visit ↗
Magellan Diagnostics	Not on record	Exited	Visit ↗
Magritek	Not on record	Current	Visit ↗
Meadowhawk Biolabs	Not on record	Current	Visit ↗
MedPharm	Not on record	Current	Visit ↗
MedVenture Technology	Not on record	Exited	Visit ↗
Nexcelom Bioscience	Not on record	Exited	Visit ↗
Nexelis	Not on record	Exited	Visit ↗
NuvinkaDx (formerly ALPCO)	Not on record	Current	Visit ↗
Phosphorex	Not on record	Current	Visit ↗
Precision Coating	Not on record	Exited	Visit ↗
ProtaGene	Not on record	Current	Visit ↗
Purna Pharma	Not on record	Current	Visit ↗
Recipharm	Not on record	Current	Visit ↗
Resolian	Not on record	Current	Visit ↗
Roadrunner Pharmacy	Not on record	Exited	Visit ↗
Signature Genomics Laboratories	Not on record	Exited	Visit ↗
Specac	Not on record	Current	Visit ↗
StageBio	Not on record	Current	Visit ↗
Syft	Not on record	Current	Visit ↗
Tjoapack	Not on record	Exited	Visit ↗
TrueCourse Biosciences (fka NanoImaging Services)	Not on record	Current	Visit ↗
Vantage MedTech	Not on record	Current	Visit ↗
Vibalogics	Not on record	Exited	Visit ↗
Viracor-IBT Laboratories	Not on record	Exited	Visit ↗
VIVEbiotech	Not on record	Current	Visit ↗
vivitide	Not on record	Exited	Visit ↗

This list is partial. We are reading the full portfolio from Ampersand Capital Partners' own site.

Source: https://ampersandcapital.com/portfolio/

Firms that also back Ampersand Capital Partners' companies

Co-investor web

Line width shows shared portfolio companies on record in the index. Top 5 co-investors shown.

EQT Partners1 shared company
Recipharm
JLL Partners1 shared company
BioClinica
Madison Dearborn Partners1 shared company
Alcami
Metalmark Capital1 shared company
Lexington Medical
Summit Partners1 shared company
LakePharma

Questions about Ampersand Capital Partners

What deals has Ampersand Capital Partners done recently?: The most recent deal on record here is: Flagship Biosciences, an Ampersand Capital Partners portfolio company, acquired Lanterne Dx (2026-10-14). This page lists 1 deal, each with its public source.

Sources for this profile, updated 2026-11-01

Firm website
Public portfolio page
Deal reports (1), linked beside each deal

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Ampersand Capital Partners and does not provide investment advice.

More PE firms

01 Advisors

Not on record

3G Capital

New York City, United States

Food productsRestaurants

3i Group

Not on record

Private EquityInfrastructure

7GC & Co.

Not on record

A&M Capital Partners

Greenwich, United States

Government ServicesIndustrial

AAC Capital Partners

Amsterdam, Netherlands

TechnologyFinancial Services

ABRY Partners

Boston, USA

Business and Facility ServicesCommunications

ABS Capital

Hunt Valley, United States

FinTechHealthcare

Browse the full PE firms directory.

Firm Intelligence

Portfolio trackedAt least 68
SectorsNot on record
RegionsNot on record
AUMNot on record

Is this your firm?

Claiming is free and reviewed by hand. Correct facts and add your portfolio or team.

Claim this profile Suggest a correction

For PE firms and deal teams

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

For PE firms and deal teamsTechnical value creation from diligence to exit.Technology due diligenceA senior, IC-ready read on a target's tech, data and security.Portfolio programsOne operating model across the portfolio: shared assessments, playbook and reporting.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.